Rogers (ROG) Q2 2025 Earnings Call Transcript

Rogers reported Q2 sales of $208 million, up 6.5% sequentially, with adjusted EPS of $0.34 and gross margin expanding 170 bps to 31.6%, but GAAP net loss was $73.6 million due to a $71.8 million curamik impairment and $4.3 million of restructuring costs. Management guided Q3 revenue to $200 million-$215 million, adjusted EPS to $0.50-$0.90, and gross margin to 31.5%-33.5%, while also announcing an incremental $13 million in curamik run-rate savings on top of $32 million previously targeted. The company remains focused on share repurchases, with $76 million still authorized, but near-term results are being pressured by EV market shifts, underutilized European capacity, and restructuring charges.

Analysis

ROG is in the middle of a classic “good quarter, bad asset” transition: the core industrial/defense/portable mix is improving, but management is simultaneously admitting the legacy EV substrate setup is structurally mispositioned. The key second-order effect is that the curamik reset should relieve margin drag before it becomes a full revenue problem, which matters because underutilized capacity can poison reported profitability faster than volume can recover it. That said, the benefit is back-end loaded; the new savings do not fully hit until late 2026, so near-term optics will remain noisy and consensus may overestimate how quickly margins re-rate.

The more interesting signal is leadership’s focus on lead-time compression and faster product cycling. If they actually cut delivery times by 50%-60%, this is not just an operational efficiency story — it expands win rates in industrial, A&D and ADAS where design-in decisions are increasingly influenced by supplier responsiveness, not just specs. That creates a potential flywheel: better service levels improve attach rates, higher utilization lifts margins, and the company can justify tighter working capital, which should partially offset the cash drag from restructuring and buybacks.

The China localization is both the strategic fix and the risk. It can restore competitiveness in EV adjacencies, but it also raises the bar: local competitors in China are likely to be faster on price and qualification, so the business could become more volume-driven and less premium-priced than the market models. The impairment suggests the old curamik valuation framework is broken; the right frame is now “industrial/defense compounder plus an option on China EV recovery,” not a steady-state EV substrate story.

Key Decisions for Investors

• Avoid chasing the stock on the quarter: wait 2-3 reporting periods to see whether lead-time and utilization improvements are real before underwriting the 2026 margin bridge.
• Consider a pairs trade: long ROG / short a higher-beta EV supply-chain substrate or power-electronics name with less balance-sheet flexibility, on the thesis that ROG’s restructuring reduces downside while preserving upside optionality.
• If you already own ROG, monetize near-term upside with covered calls 1-2 quarters out; the stock likely needs proof of execution before a multiple re-rating, and call premium can cushion restructuring noise.
• For event-driven accounts, look for a pullback entry if the market overreacts to GAAP losses; risk/reward improves if shares trade closer to cash-adjusted replacement value rather than trough earnings.
• Track China qualification milestones and Q4'26 savings realization as the real catalyst set; if these slip, the market will likely de-rate the entire transformation thesis quickly.